Stonehaven
Stonehaven, founded in 2001 and headquartered in New York City, is a global FinTech platform focused on private capital markets. It serves a diverse community of investment bankers and placement agents, facilitating transactions across various asset classes, including real estate, private equity, venture capital, private credit, hedge funds, and mergers and acquisitions. The firm engages with clients across multiple industries, such as software, healthcare, retail, media, agriculture, insurance, capital markets, manufacturing, cannabis, cybersecurity, and health technology. Stonehaven's commitment to innovation and technology enhances the efficiency of capital raising processes for its clients.
1 past transactions
Response Pharmaceuticals
Series A in 2022
Response Pharmaceuticals is a biotechnology company developing treatments for cardiometabolic risk factors associated with antipsychotic drugs. Its primary focus is on managing post-prandial triglyceride levels, body weight, and other related health issues in patients discontinuing semaglutide or tirzepatide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.